Clinical Trial Update: Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a downstaging protocol that includes immunotherapy for hepatocellular carcinoma patients beyond Milan criteria before liver …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Liver Transplantation, Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING